India's drug regulator has authorized five new companies to manufacture the life-saving injection used to treat Mucormycosis in an attempt to accelerate the production of the antifungal Amphotericin B. According to the ministry, a growing number of patients suffering from COVID
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3bOWILD
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3bOWILD